These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Balice-Gordon RJ; Smith DB; Goldman J; Cork LC; Shirley A; Cope TC; Pinter MJ Ann Neurol; 2000 May; 47(5):596-605. PubMed ID: 10805330 [TBL] [Abstract][Full Text] [Related]
24. Canine motor neuron disease: clinicopathologic features and selected indicators of oxidative stress. Green SL; Bouley DM; Pinter MJ; Cork LC; Vatassery GT J Vet Intern Med; 2001; 15(2):112-9. PubMed ID: 11300593 [TBL] [Abstract][Full Text] [Related]
25. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy. Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403 [TBL] [Abstract][Full Text] [Related]
26. Activity-driven synaptic and axonal degeneration in canine motor neuron disease. Carrasco DI; Rich MM; Wang Q; Cope TC; Pinter MJ J Neurophysiol; 2004 Aug; 92(2):1175-81. PubMed ID: 15028742 [TBL] [Abstract][Full Text] [Related]
27. RNA dysregulation in diseases of motor neurons. Ibrahim F; Nakaya T; Mourelatos Z Annu Rev Pathol; 2012; 7():323-52. PubMed ID: 22035195 [TBL] [Abstract][Full Text] [Related]
29. Canine storage disease characterized by hereditary progressive neurogenic muscular atrophy: breeding experiments and clinical manifestation. Inada S; Yamauchi C; Igata A; Osame M; Izumo S Am J Vet Res; 1986 Oct; 47(10):2294-9. PubMed ID: 3777659 [TBL] [Abstract][Full Text] [Related]
30. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
31. Changes in size of motor axons in hereditary canine spinal muscular atrophy. Cork LC; Struble RG; Gold BG; DiCarlo C; Fahnestock KE; Griffin JW; Price DL Lab Invest; 1989 Sep; 61(3):333-42. PubMed ID: 2770248 [TBL] [Abstract][Full Text] [Related]
33. Is spinal muscular atrophy the result of defects in motor neuron processes? Briese M; Esmaeili B; Sattelle DB Bioessays; 2005 Sep; 27(9):946-57. PubMed ID: 16108074 [TBL] [Abstract][Full Text] [Related]
34. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy. Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529 [TBL] [Abstract][Full Text] [Related]
35. Animal models for motor neuron disease. Green SL; Tolwani RJ Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448 [TBL] [Abstract][Full Text] [Related]
36. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages. Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606 [TBL] [Abstract][Full Text] [Related]
37. Genetic disorders of motor neurons. Cole N; Siddique T Semin Neurol; 1999; 19(4):407-18. PubMed ID: 10716663 [TBL] [Abstract][Full Text] [Related]
38. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181 [TBL] [Abstract][Full Text] [Related]
39. Spinal Muscular Atrophy: More than a Disease of Motor Neurons? Nash LA; Burns JK; Chardon JW; Kothary R; Parks RJ Curr Mol Med; 2016; 16(9):779-792. PubMed ID: 27894243 [TBL] [Abstract][Full Text] [Related]
40. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. Rich MM; Wang X; Cope TC; Pinter MJ J Neurophysiol; 2002 Dec; 88(6):3305-14. PubMed ID: 12466448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]